Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PK4M
|
|||
| Drug Name |
Isoxazole-based bicyclic compound 18
|
|||
| Synonyms |
PMID26924192-Compound-78
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ORION CORPORATION
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H21N3O4
|
|||
| Canonical SMILES |
CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)C=CC(=O)N3CC4=CC=CC=N4)OCCO
|
|||
| InChI |
1S/C22H21N3O4/c1-14-22(15(2)29-24-14)18-11-16-6-7-21(27)25(13-17-5-3-4-8-23-17)19(16)12-20(18)28-10-9-26/h3-8,11-12,26H,9-10,13H2,1-2H3
|
|||
| InChIKey |
OAVYHERNZVHDFP-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bromodomain and extraterminal domain protein (BET) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Bromodomain and extraterminal domain protein (BET) | Target's Patent Info | [1] | |
| KEGG Pathway | SNARE interactions in vesicular transport | |||
| Reactome | COPII (Coat Protein 2) Mediated Vesicle Transport | |||
| WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
| miR-targeted genes in muscle cell - TarBase | ||||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.